TAMM41
Basic information
Region (hg38): 3:11790442-11846919
Previous symbols: [ "C3orf31" ]
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 56 (Limited), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 56 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 56 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Musculoskeletal; Neurologic | 35321494 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAMM41 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 0 |
Variants in TAMM41
This is a list of pathogenic ClinVar variants found in the TAMM41 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-11790537-T-G | not specified | Uncertain significance (Sep 01, 2021) | ||
3-11790549-T-C | not specified | Uncertain significance (Jun 22, 2021) | ||
3-11790571-C-A | not specified | Uncertain significance (Feb 12, 2024) | ||
3-11807874-G-A | Uncertain significance (Sep 23, 2019) | |||
3-11809546-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
3-11809574-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
3-11809577-C-A | not specified • TAMM41-related condition | Uncertain significance (May 26, 2022) | ||
3-11809584-G-GT | Respiratory failure;Bilateral ptosis;Dysphagia;Gastroesophageal reflux • Combined oxidative phosphorylation deficiency 56 | Pathogenic (Nov 27, 2022) | ||
3-11809682-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
3-11809684-T-C | Combined oxidative phosphorylation deficiency 56 | Pathogenic (Nov 28, 2022) | ||
3-11817262-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
3-11817304-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
3-11829740-A-G | not specified | Uncertain significance (Dec 19, 2023) | ||
3-11829768-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
3-11829797-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
3-11829826-T-A | not specified | Uncertain significance (Dec 28, 2023) | ||
3-11829831-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
3-11839221-C-A | Ankle flexion contracture;Neonatal hypotonia;Bilateral ptosis;Abnormal facial shape;Proximal muscle weakness • Combined oxidative phosphorylation deficiency 56 | Pathogenic (Nov 27, 2022) | ||
3-11839223-G-A | Combined oxidative phosphorylation deficiency 56 | Pathogenic (Nov 28, 2022) | ||
3-11839235-C-A | not specified | Uncertain significance (Nov 05, 2021) | ||
3-11839235-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
3-11839304-T-C | Respiratory failure;Bilateral ptosis;Dysphagia;Gastroesophageal reflux • Combined oxidative phosphorylation deficiency 56 | Pathogenic (Nov 27, 2022) | ||
3-11844046-T-C | not specified | Uncertain significance (Nov 27, 2023) | ||
3-11844083-C-G | Combined oxidative phosphorylation deficiency 56 | Uncertain significance (-) | ||
3-11844088-T-C | not specified | Likely benign (May 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAMM41 | protein_coding | protein_coding | ENST00000273037 | 7 | 56478 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000110 | 0.808 | 125698 | 0 | 50 | 125748 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.00649 | 172 | 172 | 1.00 | 0.00000856 | 2065 |
Missense in Polyphen | 48 | 57.985 | 0.8278 | 701 | ||
Synonymous | -1.03 | 80 | 69.2 | 1.16 | 0.00000380 | 592 |
Loss of Function | 1.37 | 12 | 18.3 | 0.654 | 0.00000103 | 194 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000637 | 0.000637 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000545 | 0.000544 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.000545 | 0.000544 |
South Asian | 0.000197 | 0.000163 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the formation of CDP-diacylglycerol (CDP-DAG) from phosphatidic acid (PA) in the mitochondrial inner membrane. Required for the biosynthesis of the dimeric phospholipid cardiolipin, which stabilizes supercomplexes of the mitochondrial respiratory chain in the mitochondrial inner membrane (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.54
Haploinsufficiency Scores
- pHI
- 0.114
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tamm41
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- CDP-diacylglycerol biosynthetic process;cardiolipin biosynthetic process
- Cellular component
- extrinsic component of mitochondrial inner membrane
- Molecular function
- phosphatidate cytidylyltransferase activity;protein binding